Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 165.10
+11.20 (7.28%)
Oct 14, 2026, 4:08 PM HKT
HKG:2637 Revenue
Fujian Haixi Pharmaceuticals had revenue of 155.81M CNY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 593.90M. In the year 2025, Fujian Haixi Pharmaceuticals had annual revenue of 582.36M with 24.79% growth. That makes Fujian Haixi Pharmaceuticals the 23,690th largest company in the world by revenue and 1,406th in Hong Kong.
Revenue (ttm)
593.90M CNY
Revenue Growth
+24.79%
P/S Ratio
18.95
Revenue / Employee
2.97M CNY
Employees
200
Market Cap
12.99B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 582.36M | 115.68M | 24.79% |
| Dec 31, 2024 | 466.68M | 150.05M | 47.39% |
| Dec 31, 2023 | 316.63M | 104.17M | 49.03% |
| Dec 31, 2022 | 212.47M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.